Company Filing History:
2 out of 870 
2 out of 1,745 
2 out of 5,094 
Years Active: 2006-2010
Title: Lena Edelman: Innovator in HIV Research
Introduction
Lena Edelman is a prominent inventor based in Boulogne, France. She has made significant contributions to the field of HIV research, particularly in the development of methods to understand and inhibit the virus's mechanisms. With a total of 2 patents, her work has the potential to impact therapeutic strategies against HIV.
Latest Patents
Edelman's latest patents focus on innovative screening methods for identifying inhibitors of the human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT). The first patent addresses the induction of mitochondrial membrane permeabilization through the interaction of the HIV-1 Vpr protein with ANT. This invention provides reagents and methods for inducing or inhibiting the binding of Vpr to ANT, which is crucial for understanding mitochondrial functions and apoptosis. The second patent similarly explores mimetics and inhibitors of the interaction between Vpr and ANT, further emphasizing the importance of this research in the context of HIV.
Career Highlights
Throughout her career, Lena Edelman has worked with esteemed institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of HIV and its interactions at the cellular level.
Collaborations
Edelman has collaborated with notable researchers, including Etienne Daniel François Jacotot and Guido Kroemer. These partnerships have enriched her work and contributed to the broader scientific community's efforts in combating HIV.
Conclusion
Lena Edelman's innovative research and patents represent a significant advancement in the fight against HIV. Her contributions continue to inspire further exploration in the field of viral research and therapeutic development.